Cargando…

Correction to: Nedosiran in primary hyperoxaluria subtype 3: results from a phase I, single-dose study (PHYOX4)

Detalles Bibliográficos
Autores principales:	Goldfarb, David S., Lieske, John C., Groothoff, Jaap, Schalk, Gesa, Russell, Kerry, Yu, Shuli, Vrhnjak, Blaz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10241720/ https://www.ncbi.nlm.nih.gov/pubmed/37273015 http://dx.doi.org/10.1007/s00240-023-01455-1

Ejemplares similares

Nedosiran in primary hyperoxaluria subtype 3: results from a phase I, single-dose study (PHYOX4)
por: Goldfarb, David S., et al.
Publicado: (2023)

A Case Report of Kidney-Only Transplantation in Primary Hyperoxaluria Type 1: A Novel Approach with the Use of Nedosiran
por: Breeggemann, Matthew C., et al.
Publicado: (2023)

Primary hyperoxaluria: the pediatric nephrologist's point of view
por: Ben-Shalom, Efrat, et al.
Publicado: (2022)

A randomised Phase II/III study to evaluate the efficacy and safety of orally administered Oxalobacter formigenes to treat primary hyperoxaluria
por: Milliner, Dawn, et al.
Publicado: (2017)

Genetic assessment in primary hyperoxaluria: why it matters
por: Mandrile, Giorgia, et al.
Publicado: (2022)

Correction to: Specific populations of urinary extracellular vesicles and proteins differentiate type 1 primary hyperoxaluria patients without and with nephrocalcinosis or kidney stones
por: Jayachandran, Muthuvel, et al.
Publicado: (2021)

Transplantation outcomes in patients with primary hyperoxaluria: a systematic review
por: Metry, Elisabeth L., et al.
Publicado: (2021)

Primary hyperoxaluria type 1: novel therapies at a glance
por: Bacchetta, Justine, et al.
Publicado: (2022)

Determinants of Kidney Failure in Primary Hyperoxaluria Type 1: Findings of the European Hyperoxaluria Consortium
por: Metry, Elisabeth L., et al.
Publicado: (2023)

New Insights Regarding Organ Transplantation in Primary Hyperoxaluria Type 1
por: Sas, David J., et al.
Publicado: (2021)

Plasma oxalate and glycolate concentrations in dialysis patients with and without primary hyperoxaluria type 1
por: Metry, Elisabeth L, et al.
Publicado: (2023)

Long-Term Transplantation Outcomes in Patients With Primary Hyperoxaluria Type 1 Included in the European Hyperoxaluria Consortium (OxalEurope) Registry
por: Metry, Elisabeth L., et al.
Publicado: (2021)

Pilot study of reloxaliase in patients with severe enteric hyperoxaluria and hyperoxalemia
por: Pfau, Anja, et al.
Publicado: (2021)

Nephrocalcinosis is a risk factor for kidney failure in primary hyperoxaluria
por: Tang, Xiaojing, et al.
Publicado: (2014)

Primary Hyperoxaluria
por: Harambat, Jérôme, et al.
Publicado: (2011)

Randomized Clinical Trial on the Long-Term Efficacy and Safety of Lumasiran in Patients With Primary Hyperoxaluria Type 1
por: Hulton, Sally A., et al.
Publicado: (2021)

Successful Treatment of Primary Hyperoxaluria Type 2 with a Combined Liver and Kidney Transplant
por: Genena, Kareem M., et al.
Publicado: (2023)

ePHex: a phase 3, double-blind, placebo-controlled, randomized study to evaluate long-term efficacy and safety of Oxalobacter formigenes in patients with primary hyperoxaluria
por: Ariceta, Gema, et al.
Publicado: (2022)

Plasma Oxalate as a Predictor of Kidney Function Decline in a Primary Hyperoxaluria Cohort
por: Shah, Ronak Jagdeep, et al.
Publicado: (2020)

Development and Validation of a New Gas Chromatography–Tandem Mass Spectrometry Method for the Measurement of Enrichment of Glyoxylate Metabolism Analytes in Hyperoxaluria Patients Using a Stable Isotope Procedure
por: van Harskamp, Dewi, et al.
Publicado: (2019)

Urinary monocyte chemoattractant protein 1 associated with calcium oxalate crystallization in patients with primary hyperoxaluria
por: Wang, Xiangling, et al.
Publicado: (2020)

Primary hyperoxaluria and systemic oxalosis
por: Sriram, K., et al.
Publicado: (2007)

Enteric hyperoxaluria in chronic pancreatitis
por: Demoulin, Nathalie, et al.
Publicado: (2017)

Pyridoxine Responsiveness in a Type 1 Primary Hyperoxaluria Patient With a Rare (Atypical) AGXT Gene Mutation
por: Singh, Prince, et al.
Publicado: (2020)

Correction to Retraction of: Kidney Injury Molecule-1 Is Up-Regulated in Renal Epithelial Cells in Response to Oxalate In Vitro and in Renal Tissues in Response to Hyperoxaluria In Vivo
Publicado: (2020)

Pancytopenia as a Complication of Primary Hyperoxaluria
por: Khosravi, M., et al.
Publicado: (2019)

The Struggling Odyssey of Infantile Primary Hyperoxaluria
por: Guillaume, Adrien, et al.
Publicado: (2021)

Treatment of primary hyperoxaluria type 1
por: Gupta, Asheeta, et al.
Publicado: (2022)

Improving Treatment Options for Primary Hyperoxaluria
por: Hoppe, Bernd, et al.
Publicado: (2022)

Primary hyperoxaluria: a case series
por: Rather, Jawad Iqbal, et al.
Publicado: (2023)

Natural History of Clinical, Laboratory, and Echocardiographic Parameters of a Primary Hyperoxaluria Cohort on Long Term Hemodialysis
por: Sas, David J., et al.
Publicado: (2021)

Specific populations of urinary extracellular vesicles and proteins differentiate type 1 primary hyperoxaluria patients without and with nephrocalcinosis or kidney stones
por: Jayachandran, Muthuvel, et al.
Publicado: (2020)

Bilateral nephrocalcinosis in primary hyperoxaluria type 1
por: Mansoor, C. A., et al.
Publicado: (2016)

Primary Hyperoxaluria Involving the Liver With Crystal Deposits
por: Bansal, Nalini, et al.
Publicado: (2019)

ALLN-177, oral enzyme therapy for hyperoxaluria
por: Lingeman, James E., et al.
Publicado: (2019)

Is stiripentol truly effective for treating primary hyperoxaluria?
por: Martin-Higueras, Cristina, et al.
Publicado: (2020)

Primary hyperoxaluria type 1: pathophysiology and genetics
por: Fargue, Sonia, et al.
Publicado: (2022)

Primary hyperoxaluria: the adult nephrologist's point of view
por: Moochhala, Shabbir H, et al.
Publicado: (2022)

Clinical and molecular characterization of primary hyperoxaluria in Egypt
por: Soliman, Neveen A., et al.
Publicado: (2022)

Dietary hyperoxaluria is not reduced by treatment with lactic acid bacteria
por: Siener, Roswitha, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_kdakousai0i1n5ms9hpjgm3srt